Evidence map›Paper›PMID 28123079›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Zika Virus Targeting in the Developing Brain.

Anthony N van den Pol, Guochao Mao, Yang Yang, Sara Ornaghi, John N Davis

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Zika virus infection histories in brain development.Disease models & mechanisms · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Mechanisms of Zika astrocyte infection and neuronal toxicity.NeuroImmune pharmacology and therapeutics · 2023
    Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anthony N van den PolDepartment of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06520 anthony.vandenpol@yale.edu.
Guochao MaoDepartment of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06520.
Yang YangDepartment of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06520.
Sara OrnaghiDepartment of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06520.ORCID 0000-0001-6898-7217
John N DavisDepartment of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06520.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Lassa-VSV targets and kills glioma, and is not neurotoxicR01CA188359 · NCI · YALE UNIVERSITY · PI GUNEL, MURAT · 2015 to 2020
$1.9M
LuIII parvovirus targets gliomaR01CA175577 · NCI · YALE UNIVERSITY · PI VAN DEN POL, ANTHONY N · 2013 to 2015
$1.0M
NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA175577NCI NIH HHS R01 CA188359
6 · The paper itself

Abstract

Zika virus (ZIKV), a positive-sense RNA flavivirus, has attracted considerable attention recently for its potential to cause serious neurological problems, including microcephaly, cortical thinning, and blindness during early development. Recent findings suggest that ZIKV infection of the brain can occur not only during very early stages of development, but also in later fetal/early neonatal stages of maturation. Surprisingly, after peripheral inoculation of immunocompetent mice on the day of birth, the first cells targeted throughout the brain were isolated astrocytes. At later stages, more neurons showed ZIKV immunoreactivity, in part potentially due to ZIKV release from infected astrocytes. In all developing mice studied, we detected infection of retinal neurons; in many mice, this was also associated with infection of the lateral geniculate, suprachiasmatic nuclei, and superior colliculus, suggesting a commonality for the virus to infect cells of the visual system. Interestingly, in mature mice lacking a Type 1 interferon response (IFNR

Indexed as

BrainAnimalsAnimals, NewbornAntiviral AgentsCell Line, TransformedCells, CulturedDisease Models, AnimalGene Expression Regulation, ViralHumansImmunocompromised HostInterferonsMental DisordersMiceMice, TransgenicNervous System DiseasesNeurogliaAntiviral AgentsInterferonsReceptors, Interferonastrocytebehavior dysfunctiondevelopmentinfectionneurotropicvirus

Identifiers

PMID28123079
PMCPMC5338758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.